整合性单细胞和空间转录组揭示S100A16瘤内皮细胞驱动血管生成和免疫抑制在肝细胞癌

Xiang-Xu Wang1, Shuo Jin2, Xiaoting Chao1

  • 1Department of Clinical Oncology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China; Innovation Research Institute, Xijing Hospital, Air Force Medical University, Xi'an, China.

Cancer letters
|February 21, 2026
PubMed
概括

研究人员确定了一种特定类型的与瘤相关的内皮细胞 (S100A16+ TECs),通过促进血管生长和免疫抑制,驱动肝癌 (肝细胞癌) 的进展. 这些细胞可以作为免疫治疗的治疗标和生物标记物.